Abstract
The pharmaceutical industry faces continuing pressures from rising R&D costs, depreciating value of patents and pressures from public authorities to cut healthcare costs. These challenges have increased the focus on shortening development times and the efficiency of Front-End of Innovation (FEI). This paper explores how idea management may be applied as a tool in facilitation of pharmaceutical FEI, which is studied through an exploratory case study of six medium to large pharmaceutical companies. The derived findings reveal several key similarities, which have implications for policy-makers and the way FEI should be supported in Pharma.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Technology, Policy and Management
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
